C5ORF33 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.20774526332934E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.24790000555208E-09 |
Normal-vs-Stage2 |
2.34869999999887E-05 |
Normal-vs-Stage3 |
1.94049998292201E-10 |
Normal-vs-Stage4 |
9.96650539875077E-11 |
Stage1-vs-Stage2 |
6.736800E-01 |
Stage1-vs-Stage3 |
9.115600E-02 |
Stage1-vs-Stage4 |
1.471660E-02 |
Stage2-vs-Stage3 |
5.550000E-01 |
Stage2-vs-Stage4 |
2.379000E-01 |
Stage3-vs-Stage4 |
3.922200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.2712053631958E-11 |
Normal-vs-AfricanAmerican |
1.96289651199777E-11 |
Normal-vs-Asian |
7.343500E-03 |
Caucasian-vs-AfricanAmerican |
8.218000E-03 |
Caucasian-vs-Asian |
5.545200E-01 |
AfricanAmerican-vs-Asian |
8.086800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.59312621059871E-14 |
Normal-vs-Female |
2.67969999523388E-08 |
Male-vs-Female |
7.713900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.04980468762506E-11 |
Normal-vs-Age(41-60Yrs) |
5.27220489487945E-11 |
Normal-vs-Age(61-80Yrs) |
6.5437999463569E-10 |
Normal-vs-Age(81-100Yrs) |
2.244800E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.377800E-03 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.036800E-04 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.278020E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.261400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.608400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.771600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.647650E-02 |
Normal-vs-Grade 2 |
7.10070000020657E-07 |
Normal-vs-Grade 3 |
1.6493999499545E-09 |
Normal-vs-Grade 4 |
1.49880108324396E-14 |
Grade 1-vs-Grade 2 |
9.307200E-01 |
Grade 1-vs-Grade 3 |
4.424800E-01 |
Grade 1-vs-Grade 4 |
6.060700E-03 |
Grade 2-vs-Grade 3 |
2.691600E-02 |
Grade 2-vs-Grade 4 |
3.61509999713405E-08 |
Grade 3-vs-Grade 4 |
1.208950E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.595800E-04 |
Normal-vs-ccB subtype |
3.3930636078594E-12 |
ccA subtype-vs-ccB subtype |
1.31589994456505E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.57879995135823E-09 |
Normal-vs-N1 |
1.59310999999773E-05 |
N0-vs-N1 |
5.918300E-02 |
|
|